• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand

    TriMed Closes Out FDA Warning Letter

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    TriMed Closes Out FDA Warning Letter

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    ARCH Medical Solutions

    Five Star Manufacturing Inc.

    Tecomet

    Tegra Medical

    Nelson Laboratories LLC
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    Bioelectronic Medicine Gets on Arthritis’ Last Nerve

    Related CONTENT
    • Medtronic Enrolls First Patient in Pain Study to Assess Spinal Cord Stimulation Programming
    • Biological Building Blocks
    • Global Orthopedics Market to Grow to $66.2 Billion by 2023
    • Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arthritis
    • Paradigm Spine Expands Leadership Team with Four New Appointments
    Sam Brusco, Associate Editor05.29.18
    According to Northwell Health, as of 2016 rheumatoid arthritis (RA) affects 1.3 million adults in the U.S. And despite billions of dollars spent annually treating the disease, there has yet to be a therapeutic agent able to universally relieve the joint pain and inflammation that characterize the chronic and often disabling disease. Treatments targeting tumor necrosis factor (TNF)—a molecule that precipitates inflammation—has found relief for some RA patients, but is ineffective for about half of those suffering from RA.

    Vagus nerve stimulators have been used to treat epilepsy that is unresponsive to medication, but may also bring about welcome relief for RA patients. Initial studies have shown that TNF production can be inhibited by stimulating the vagus nerve, forming the basis for a 2016 study published in the Proceedings of the National Academy of Science (PNAS), led by the Feinstein Institute for Medical Research, the Academic Medical Center at the University of Amsterdam, and medical technology company SetPoint Medical.

    During the study, 17 patients received implanted vagus nerve stimulators. Each device’s degree of stimulation was tailored to consider individual patients’ tolerances, and delivered a small amount of electrical current to the vagus nerve for 60 seconds, four times daily. At 42 days, TNF production was found to be dramatically reduced, improving the RA symptoms of tender and swollen joints, patients’ assessments of pain, physicians’ evaluations of patients, and C-reactive protein levels. At 84 days, TNF production was further impeded and symptom severity slashed, even in patients whose RA had not responded to any other therapies.

    Based on this study, in December of last year, SetPoint Medical, a Santa Clarita, Calif.-based clinical-stage biomedical technology company developing an implantable bioelectronic medicine therapy for chronic inflammatory diseases, was granted Investigational Device Exemption (IDE) approval from the FDA to commence a pilot trial in the U.S. for patients with drug refractory RA.

    “We are ready to build on the published positive data from our earlier first-in-human proof-of-concept study of bioelectronic therapy in RA, which significantly improved measures of RA disease activity in this difficult-to-treat patient population and also inhibited cytokine production,” David Chernoff, M.D., chief medical officer of SetPoint Medical, said in a company announcement detailing the FDA approval. “The new trial will evaluate SetPoint’s advanced generation proprietary miniaturized, rechargeable wireless implanted device. This novel device will be used to stimulate the vagus nerve in order to activate the efferent arm of the Inflammatory Reflex known as the Cholinergic Anti-inflammatory Pathway (CAP).”

    The pilot trial for SetPoint’s bioelectronic therapy for drug refractory RA began in late March. It aims to assess the safety and efficacy of the company’s device in adult patients with RA who are inadequately responsive to multiple biologic agents.

    “Despite the effectiveness of biologic and targeted agents for the treatment of rheumatoid arthritis, many patients either do not respond, lose therapeutic response, or are intolerant to these agents,” Mark C. Genovese, M.D., principal investigator and the James W. Raitt professor of Medicine and director of the Rheumatology Clinic in the Division of Immunology and Rheumatology at Stanford University Medical Center, said in a statement announcing the pilot trial’s launch. “There remains a real need to develop alternative therapeutic approaches for the treatment of patients with drug refractory disease. Bioelectronic medicine represents a novel and promising approach for patients who need other options for treatment of their rheumatoid arthritis.”

    Bioelectronic medicines (also known as electroceuticals or neuromodulation) like SetPoint’s implantable vagus nerve stimulator may prove to be a healthier and lower-cost alternative to drug therapy for treating chronic inflammatory diseases. The implanted system is meant to last 10 years, freeing patients from routine injections or pills and reducing the risks and hefty cost associated with traditional biologic treatments. It can benefit physicians as a novel and less costly alternative for RA patients, and payors as well can reap the benefit of improved patient lives while potentially decreasing the cost of treatment by half or more.

    Electroceuticals may be the most promising and fastest-growing alternative to drugs. According to the Boston Globe, the field has attracted over $1 billion of investment over the past three years—including both startups like SetPoint as well as pharmaceutical and medtech heavyweights like Boston Scientific Corp., GSK, Medtronic plc, and Google’s parent company Alphabet. SetPoint Medical itself has also accrued investment money from Boston Scientific, GSK, and Medtronic, as well as from investors Morgenthaler Ventures, NEA, and Topspin Partners.

    SetPoint’s platform consists of an implantable microregulator, wireless charger, and iPad prescription pad application. The company plans to expand its bioelectronics platform for therapies to target other chronic inflammatory diseases outside of the orthopedic space as well, including Crohn’s disease.

    “I have conducted more than 100 clinical trials, and it is incredibly exciting to be the first center in the U.S. to enroll a subject in this trial of SetPoint Medical’s bioelectronic modulation system for the treatment of patients with rheumatoid arthritis who have had inadequate responses to multiple treatments,” said Norman Gaylis, M.D., MACR, FACP, nationally recognized rheumatologist and CEO of clinical research organization AARDS Research Inc. “The opportunity to try a completely different therapeutic approach for my RA patients will hopefully lead to another treatment option for this very debilitating disease.”  
    Related Searches
    • medical
    • technology
    • medtronic
    • orthopedic
    Suggested For You
    Will Additive Manufacturing Revolutionize Orthopedic Product Manufacture? Will Additive Manufacturing Revolutionize Orthopedic Product Manufacture?
    U.S. Orthopedic Devices Market to Witness Massive Growth Over 2017-2024 U.S. Orthopedic Devices Market to Witness Massive Growth Over 2017-2024
    U.S. Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arthritis U.S. Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arthritis
    Medtronic Launches Titanium 3D-Printed Platform for Spine Surgery Implants Medtronic Launches Titanium 3D-Printed Platform for Spine Surgery Implants
    FDA Approves Medtronic FDA Approves Medtronic's Infuse Bone Graft for Use with PEEK Spine Implants
    Paradigm Spine Expands Leadership Team with Four New Appointments Paradigm Spine Expands Leadership Team with Four New Appointments
    Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arthritis Pilot Trial to Evaluate First Bioelectronic Device to Treat Rheumatoid Arthritis
    Global Orthopedics Market to Grow to $66.2 Billion by 2023 Global Orthopedics Market to Grow to $66.2 Billion by 2023
    Biological Building Blocks Biological Building Blocks
    Medtronic Enrolls First Patient in Pain Study to Assess Spinal Cord Stimulation Programming Medtronic Enrolls First Patient in Pain Study to Assess Spinal Cord Stimulation Programming

    Related Columns

    • Extremities
      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Toe Fusion Alternatives Gaining a Firm Market Foothold

      Dr. Carl Hasselman, co-designer of the Arthrosurface ToeMotion Arthroplasty System, speaks about non-fusion alternatives for MTPJ osteoarthritis.
      Michael Barbella, Managing Editor 12.02.19

    • The Cluster Effect in Orthopedics: Is It Sustainable?

      The Cluster Effect in Orthopedics: Is It Sustainable?

      For a long time, we all assumed Minnesota dominated the medical device industry worldwide, but is this true for the orthopedic surgical tools industry?
      Maria Shepherd, President and Founder, Medi-Vantage 12.02.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 12.02.19


    • Turning the New EU MDR Into a Competitive Advantage

      Turning the New EU MDR Into a Competitive Advantage

      This column examines three new elements of the EU MDR that medical device manufacturers can leverage.
      Dan Goldstein, Associate Director, Quality Assurance, MCRA LLC 12.02.19

    • Design | Large Joint | Spine/Neurology
      Five Reasons for the Small World of Orthopedic Product Development

      Five Reasons for the Small World of Orthopedic Product Development

      Why do product development people tend to stay within the orthopedic and spine industry and not cross over into other medtech sectors?
      Victoria Trafka, BSME, MSME, President and Lead Engineer, Engineering & Quality Solutions Inc. 12.02.19

    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff, and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 12.02.19


    • Spine/Neurology
      Pediatric Orthopedics Taken Off the Back Burner

      Pediatric Orthopedics Taken Off the Back Burner

      There are several different types of scoliosis, a condition that causes a sideways spinal curve, that affect children and adolescents.
      Sam Brusco, Associate Editor 09.17.19

    • What Are Orthopedic Surgeon Salary and Employment Statistics?

      What Are Orthopedic Surgeon Salary and Employment Statistics?

      The percent of employed physicians is greater than self-employed physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 09.17.19

    • U.S. May Offer a Safe Harbor from the Impending MDR Storm

      U.S. May Offer a Safe Harbor from the Impending MDR Storm

      There are factors that make for a more inviting environment for the medical device industry in the United States.
      Dawn A. Lissy, President & Founder, Empirical 09.17.19


    • How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      How Identifying Gaps in Clinical Data Can Ease the Transition to New Regulations

      As of 2017, the European medical device market was estimated  at $126 billion, the second largest worldwide, comprising 27 percent of the global market. The European market trails only the United States, which accounts for roughly 43 percent of…
      Mike Goodson, Associate Director, Regulatory Affairs, MCRA LLC 09.17.19

    • Software & Quality
      Benefiting from Paperless Production Records: A Case Study

      Benefiting from Paperless Production Records: A Case Study

      EpiBone discovered how eliminating paper with digital production records can help ensure data integrity, reduce errors, and increase efficiency.
      Terrance Holbrook, Director of Product, MasterControl 09.17.19

    • Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      San Francisco is globally renowned for many things: The Golden Gate Bridge (its color, international orange, was actually a primer used to protect the steel during transit), Ghirardelli chocolate, the TransAmerica pyramid building, and the “Pai…
      ODT Staff 08.14.19

    • What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      What Keeps Hospital CEOs Awake at Night and How Can Medtech Help?

      With the continued surge of mergers and acquisitions, vertical integrations, and no clear U.S. policy or reform direction for our $3.6 trillion annual healthcare spend,1 the healthcare ecosystem remains in a phase of dramatic disruption. What Is K…
      Maria Shepherd, President and Founder, Medi-Vantage 08.14.19

    • Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

      I’m generally an optimistic person. My outgoing voicemail greeting encourages every caller to “keep smiling!” My wardrobe is about 40 percent “Life is Good” apparel and I keep a daily gratitude journal. Despite this s…
      Dawn A. Lissy, President & Founder, Empirical 08.14.19

    • Successful Strategies for Health Plan Medical Policy Outreach

      Successful Strategies for Health Plan Medical Policy Outreach

      Getting approval from the FDA can be a significant achievement for a company but a bigger challenge awaits for novel technologies: health payor acceptance and coverage. Adopting a novel technology does not occur easily due to complex commercial insur…
      Chelsey Jaworski and Anabel Tapia, MCRA 08.14.19


    Breaking News
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    • TriMed Closes Out FDA Warning Letter
    • FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    • OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    MedStar Health and Cleveland Clinic Innovations Awarded Grant
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.